3D OCT-1
Device
TOPCON MEDICAL SYSTEMS, INC.
Total Payments
$418,276
Transactions
19
Doctors
4
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $418,276 | 19 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $418,276 | 19 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TOPCON MAESTRO2 OCT ANGIOGRAPHY SOFTWARE EVALUATION STUDY | TOPCON MEDICAL SYSTEMS, INC. | $231,911 | 1 |
| INVESTIGATION OF A REAL WORLD OCT REFERENCE DATABASE | TOPCON MEDICAL SYSTEMS, INC. | $176,365 | 3 |
| FEASIBILITY EVALUATION USING DOPPLER OCT BLOOD FLOW MEASUREMENT FOR ASSESSING OCULAR CIRCULATION IN RETINAL AND OPTIC NERVE DISEASES | TOPCON CORPORATION | $10,000 | 0 |
Ad
Manufacturing Companies
- TOPCON MEDICAL SYSTEMS, INC. $408,276
- TOPCON CORPORATION $10,000
Product Information
- Type Device
- Total Payments $418,276
- Total Doctors 4
- Transactions 19
About 3D OCT-1
3D OCT-1 is a device associated with $418,276 in payments to 4 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is TOPCON MEDICAL SYSTEMS, INC..
Payment data is available from 2023 to 2023. In 2023, $418,276 was paid across 19 transactions to 4 doctors.
The most common payment nature for 3D OCT-1 is "Unspecified" ($418,276, 100.0% of total).
3D OCT-1 is associated with 3 research studies, including "TOPCON MAESTRO2 OCT ANGIOGRAPHY SOFTWARE EVALUATION STUDY" ($231,911).